Mineralys Therapeutics MLYS
NASDAQ MLYS
$15.63 +0.11 (+0.71%)
As of: Nov 11, 2026 · 1:06 PM EST

Mineralys Therapeutics (MLYS) Long-Term Investments (2023)

Updated

Mineralys Therapeutics' Long-Term Investments was $2.48 million in Q4 2023, down 79.5% from the prior quarter.

Analysis

Mineralys Therapeutics (MLYS) Long-Term Investments (2023) Analysis & Trends

From Q1 2023 onward, Mineralys Therapeutics has reported Long-Term Investments for 4 quarters.

  • Per Business Quant data, MLYS's Long-Term Investments in the three quarters before Q4 2023 was $12.13 million (Q3 2023), $21.68 million (Q2 2023) and $31.12 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Mineralys Therapeutics 1.37 Bn -1.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.48 Mn
Sep 30, 2023 12.13 Mn
Jun 30, 2023 21.68 Mn
Mar 31, 2023 31.12 Mn
API Access

Mineralys Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=MLYS&period=max&api_key=YOUR_API_KEY